Homozygosity of the interleukin-10 receptor 1 G330R allele is associated with schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 3, 2007, Pages 347-350

  Schosser, Alexandra ^a   Aschauer, Harald N ^a   Wildenauer, Dieter B ^b   Schwab, Sibylle G ^b,c   Albus, Margot ^d   Maier, Wolfgang ^c   Schloegelhofer, Monika ^a   Leisch, Friedrich ^e   Hornik, Kurt ^f   Murray, Sarah S ^g   Gasche, Christoph ^a,h  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF BONN   (Germany)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

^g ILLUMINA INC   (United States)

^h UNIVERSITY OF VIENNA   (Austria)

Author keywords

IL 10R1; Schizoaffective disorder; Schizophrenia

Indexed keywords

ARGININE; GENOMIC DNA; GLYCINE; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR 1; MUTANT PROTEIN; SERINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; AUSTRIA; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GERMANY; HOMOZYGOSITY; HUMAN; IL 10R1 GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT; RECEPTOR GENE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARGININE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCINE; HOMOZYGOTE; HUMANS; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; LINKAGE (GENETICS); MALE; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 34247367971     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30416     Document Type: Article

References (23)

1. Abel L, Muller-Myhsok B. 1998. Maximum-likelihood expression of the transmission/disequilibrium test and power considerations. Am J Hum Genet 63:664-667.
2. American Psychiatric Association. 1987. Diagnostic and statistical manual of mental disorders (DSMIII-R), revised 3rd edn. American Psychiatric Association, Washington DC.
3. Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M. 1998. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog Neuropsychopharmacol Biol Psychiatry 22: 947-957.
4. Chabot S, Williams G, Hamilton M, Sutherland G, Yong VW. 1999. Mechanisms of IL-10 production in human microglia-T cell interaction. J Immunol 162:6819-6828.
5. Eskdale J, Kube D, Tesch H, Gallagher G. 1997. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46:120-128.
6. Gasche C, Grundtner P, Zwirn P, Reinisch W, Shaw HS, Zdanov A, Sarma U, Williams LM, Foxwell BM, Gangl A. 2003. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-α production. J Immunol 170:5578-5582.
7. Gurling H, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blavery E, McQuillin A, Petursson H, Curtis D. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for Schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to Schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661-673.
8. Hofer H, Neufeld JB, Oesterreicher C, Grundtner P, Wrba F, Gangl A, Ferenci P, Gasche C. 2005. Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun 6:242-247.
9. Jones BC, Logsdon NJ, Josephson K, Cook J, Barry PA, Walter MR. 2002. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci USA 99:9404-9409.
10. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 97:1695-1700.
11. Liu Y, Wei SH, Ho AS, de Waal M, Moore KW. 1994. Expression cloning and characterization of a human IL-10 receptor. J Immunol 152:1821-1829.
12. Liu Y, de Waal M, Briere F, Parham C, Bridon JM, Banchereau J, Moore KW, Xu J. 1997. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158:604-613.
13. Maziade M, Raymond V, Cliche D, Forunier JP, Caron C, Garneau Y, Nicole L, Marcotte P, Couture C, Simard C, Biovin R, Rodrigue C, Boutin P, DeBraekeleer M, Martinez M, Merette C. 1995. Linkage results on 11q21-22 in eastern Quebec pedigrees densely affected by schizophrenia. Am J Med Genet 60:522-528.
14. Moore KW, Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Rev Immunol 19:683-765.
15. Müller N. 2004. Immunological and infectious aspects of schizophrenia. Eur Arch Psychiatry Clin Neurosci 254:1-3.
16. Nanko S, Gill M, Owen M, Takazawa N, Moridaira J, Kazamatsuri H. 1992. Linkage study of schizophrenia with markers on chromosome 11 in two Japanese pedigrees. Jpn J Psychiatry Neurol 46:155-159.
17. R Development Core Team. 2005. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org).
18. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H. 1996. Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry 40:1294-1297.
19. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
20. Spitzer RL, Endicott J. 1987. Schedule for Affective Disorders and Schizophrenia (SADS). New York, Biometrics Research Division, New York State Psychiatric Institute.
21. Taniyama T, Takai S, Miyazaki E, Fukumura R, Sato J, Kobyashi Y, Hirakawa T, Moore KW, Yamada K. 1995. The human interleukin-10 receptor gene maps to chromosome 11q23.3. Hum Genet 95:99-101.
22. Van Kammen DP, McAllister-Sistilli CG, Kelly ME. 1997. Relationship between immune and behavioral measures in schizophrenia. In: Wieselmann G, editor, current Update in psychoimmunology. New York: Springer Verlag Wien. pp 51-55.
23. Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC. 2002. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: Association with psychopathology. Schizophr Res 57:247-258.